Relative Bioavailability With PF-05089771 Capsule Versus Oral Dispersion

NCT01854996 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer